Literature DB >> 29386078

Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.

J Buyze1, W Vanden Berghe1, N Hens2, C Kenyon1.   

Abstract

There is considerable uncertainty as to the effectiveness of Neisseria gonorrhoeae (NG) screening in men who have sex with men. It is important to ensure that screening has benefits that outweigh the risks of increased antibiotics resistance. We develop a mathematical model to estimate the effectiveness of screening on prevalence. Separable Temporal Exponential family Random Graph Models are used to model the sexual relationships network, both with main and casual partners. Next, the transmission of Gonorrhoea is simulated on this network. The models are implemented using the R package 'statnet', which we adapted among other things to incorporate infection status at the pharynx, urethra and rectum separately and to distinguish between anal sex, oral sex and rimming. The different screening programmes compared are no screening, 3.5% of the population screened, 32% screened and 50% screened. The model simulates day-by-day evolution for 10 years of a population of 10 000. If half of the population would be screened, the prevalence in the pharynx decreases from 11.9% to 10.2%. We conclude that the limited impact of screening on NG prevalence may not outweigh the increased risk of antibiotic resistance.

Entities:  

Keywords:  zzm321990 Neisseria gonorrhoeaezzm321990 ; MSM; Mathematical modelling; screening

Mesh:

Year:  2018        PMID: 29386078      PMCID: PMC9134539          DOI: 10.1017/S0950268818000092

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  40 in total

1.  Pharyngeal neisseria gonorrhoeae: coloniser or pathogen?

Authors:  J Wallin; M S Siegel
Journal:  Br Med J       Date:  1979-06-02

2.  British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011.

Authors:  D Asboe; C Aitken; M Boffito; C Booth; P Cane; A Fakoya; A M Geretti; P Kelleher; N Mackie; D Muir; G Murphy; C Orkin; F Post; G Rooney; C Sabin; L Sherr; E Smit; W Tong; A Ustianowski; M Valappil; J Walsh; M Williams; D Yirrell
Journal:  HIV Med       Date:  2012-01       Impact factor: 3.180

3.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

4.  Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.

Authors:  Samuel M Jenness; Kevin M Weiss; Steven M Goodreau; Thomas Gift; Harrell Chesson; Karen W Hoover; Dawn K Smith; Albert Y Liu; Patrick S Sullivan; Eli S Rosenberg
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

5.  Screening for Neisseria gonorrhoeae and Chlamydia trachomatis at entertainment venues among men who have sex with men.

Authors:  Joseph Debattista; Chris Clementson; Drew Mason; John Dwyer; Shelly Argent; Charlotte Woodward; Judith Dean; Lorraine Buks; Mark Copley; Greg Hinwood; Craig Benfield; Paul Walton
Journal:  Sex Transm Dis       Date:  2002-04       Impact factor: 2.830

6.  The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries.

Authors:  Roger Detels; Annette M Green; Jeffrey D Klausner; David Katzenstein; Charlotte Gaydos; H Hunter Handsfield; Willo Pequegnat; Kenneth Mayer; Tyler D Hartwell; Thomas C Quinn
Journal:  Sex Transm Dis       Date:  2011-06       Impact factor: 2.830

7.  Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae.

Authors:  K K Fox; J C Thomas; D H Weiner; R H Davis; P F Sparling; M S Cohen
Journal:  Am J Epidemiol       Date:  1999-02-15       Impact factor: 4.897

Review 8.  Is gonorrhea becoming untreatable?

Authors:  Paula Bianca Blomquist; Victoria F Miari; Jane P Biddulph; Bambos M Charalambous
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 9.  The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2013-12       Impact factor: 3.519

10.  Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men.

Authors:  H Grosskurth; P Mayaud; F Mosha; J Todd; K Senkoro; J Newell; R Gabone; J Changalucha; B West; R Hayes
Journal:  BMJ       Date:  1996-02-03
View more
  6 in total

1.  Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis.

Authors:  Rebecca Earnest; Minttu M Rönn; Meghan Bellerose; Thomas L Gift; Andrés A Berruti; Katherine K Hsu; Christian Testa; Lin Zhu; Yelena Malyuta; Nicolas A Menzies; Joshua A Salomon
Journal:  Sex Transm Dis       Date:  2020-07       Impact factor: 3.868

2.  Association between intensity of STI screening and development of antimicrobial resistance in N. gonorrhoeae in 12 cities in the USA: An ecological study.

Authors:  Chris R Kenyon
Journal:  F1000Res       Date:  2018-08-10

Review 3.  Effects of Sexual Network Connectivity and Antimicrobial Drug Use on Antimicrobial Resistance in Neisseria gonorrhoeae.

Authors:  Chris R Kenyon; Ilan S Schwartz
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

4.  Toward a Set of Criteria to Decide Which STIs to Screen for in PrEP Cohorts.

Authors:  Chris Kenyon
Journal:  Front Public Health       Date:  2019-06-12

5.  Does gonorrhoea screening intensity play a role in the early selection of antimicrobial resistance in men who have sex with men (MSM)? A comparative study of Belgium and the United Kingdom.

Authors:  Chris R Kenyon; Irith De Baetselier; Tania Crucitti
Journal:  F1000Res       Date:  2018-05-10

6.  Screening is not associated with reduced incidence of gonorrhoea or chlamydia in men who have sex with men (MSM); an ecological study of 23 European countries.

Authors:  Chris Kenyon
Journal:  F1000Res       Date:  2019-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.